Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program

PURPOSE: The aim of this study was to confirm the efficacy and safety of regorafenib for advanced gastrointestinal stromal tumors (GISTs) reported in the GRID phase III trial in Korean patients. MATERIALS AND METHODS: Fifty-seven Korean patientswith advanced GISTwho experienced both imatinib and sun...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Res Treat
Hauptverfasser: Son, Myoung Kyun, Ryu, Min-Hee, Park, Joon Oh, Im, Seock-Ah, Kim, Tae-Yong, Lee, Su Jin, Ryoo, Baek-Yeol, Park, Sook Ryun, Kang, Yoon-Koo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Cancer Association 2017
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398393/
https://ncbi.nlm.nih.gov/pubmed/27456941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.067
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge